Di Lauro, L <br/><br/>
Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.  [electronic resource] 

 -  Tumori   
 - 42-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0300-8916 
<br/><br/><label>Standard No.: </label>10.1177/030089169508100110  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carcinoma, Renal Cell--therapy<br/>Drug Administration Schedule<br/>Drug Synergism<br/>Female<br/>Humans<br/>Injections, Subcutaneous<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--therapy<br/>Male<br/>Middle Aged<br/>Recombinant Proteins<br/>Thymopentin--administration & dosage